Hervé Devilliers

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18–20 September 2015

Oakley, A. Mammen, J. Hogrel, 2016, Neuromuscular Disorders.

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

P. Grenier, M. Guiguet, E. Hachulla, 2015, PloS one.